Effect of laparoscopic sleeve gastrectomy on lipid profile of obese patients in complete nine month follow up

Sanjay Singhal; Dhiraj Agarwal; Rajkamal Kanojiya; Devansh Arora; Ankur Avesthi; Ankur Kothari

doi:10.18203/2349-2902.isj20151486

Authors

Sanjay Singhal Department of General Surgery, Mahatma Gandhi Medical College and Hospital, Sitapura, Jaipur, Rajasthan 302022, India
Dhiraj Agarwal Department of General Surgery, Mahatma Gandhi Medical College and Hospital, Sitapura, Jaipur, Rajasthan 302022, India
Rajkamal Kanojiya Department of General Surgery, Mahatma Gandhi Medical College and Hospital, Sitapura, Jaipur, Rajasthan 302022, India
Devansh Arora Department of General Surgery, Mahatma Gandhi Medical College and Hospital, Sitapura, Jaipur, Rajasthan 302022, India
Ankur Avesthi Department of General Surgery, Mahatma Gandhi Medical College and Hospital, Sitapura, Jaipur, Rajasthan 302022, India
Ankur Kothari Department of General Surgery, Mahatma Gandhi Medical College and Hospital, Sitapura, Jaipur, Rajasthan 302022, India

DOI:

https://doi.org/10.18203/2349-2902.isj20151486

Keywords:

Obesity, Bariatric surgery, Laparoscopic sleeve gastrectomy, Dyslipidemia

Abstract

Background: Obesity is very serious issue in world now days as it has become the global epidemic and major problem in the 21st century which influences many aspects of health. Bariatric surgery has proven to be an effective treatment against obesity and its related co morbidities. Laparoscopic sleeve gastrectomy (LSG) has shown resolution of dyslipidemia in more than 85% of patients in one year. The aim of the study was to monitor the changes of lipid profile in selected parameters for nine months postoperatively.

Methods: The material consist of 50 patient hospitalized in our department of Minimal Invasive Surgery from 2014 to 2015 who underwent LSG in order to treat morbid obesity. Remission of dyslipidemia was defined as return to normal value after Laparoscopic sleeve gastrectomy (LSG) without medication use.

Results: Our study shows that LSG resolved or improved lipid profile in a majority of patients. The main obesity related metabolic risk factors of CVS involve low serum HDL cholesterol level with increased level of TG and LDL level. During initial first 6 month of after surgery significant change in lipid profile reported specially an increase of HDL cholesterol, decrease in TG level and LDL cholesterol.

Conclusions: Nine month after operation improve metabolism and lipid profile was accompanied by decrease in Total Cholesterol, Triglyceride and LDL cholesterol and increase in HDL cholesterol change in significant way.

Metrics

Metrics Loading ...

References

World Health Organization. Obesity. Preventing and Managing the Global Epidemic. World Health Organ Tech Rep Ser. 2000;No.894.

India facing obesity epidemic: experts. The Hindu. 2007-10-12.

Indian Heart Association Webpage 26 April 2015. <http://indianheartassociation.org/>

Nieves DJ, Cnop M, Retzlaff B, Walden CE, Brunzell JD. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes. 2003;52:172-9.

Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567-76.

Brethauer SA, Aminian A, Romero-Talamás H, Batayyah E, Mackey J. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258:628-36.

Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-37.

Wilhelm SM, Young J, Kale-Pradhan PB. The Effect of Bariatric Surgery on Hypertension: A Meta-analysis. Ann Pharmacother. 2014;48:674-82.

Boza C, Salinas J, Salgado N, Pérez G, Raddatz A. Laparoscopic sleeve gastrectomy as a stand-alone procedure for morbid obesity: report of 1,000 cases and 3-year follow-up. Obes Surg. 2012;22:866-71.

Ruiz-Tovar J, Oller I, Tomas A, Llavero C, Arroyo A. Midterm impact of sleeve gastrectomy, calibrated with a 50-Fr bougie, on weight loss, glucose homeostasis, lipid profiles, and comorbidities in morbidly obese patients. Am Surg. 2012;78:969-74.

Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obesity Surgery. 1998;8(3):267–82.

Chiu S, Birch DW, Shi X, Sharma AM, and Karmali S. Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review. Surgery for Obesity and Related Diseases. 2011;7(4):510–5.

Gill RS, Birch DW, Shi X, Sharma AM, Karmali S. “Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review,” Surgery for Obesity and Related Diseases. 2010;6(6):707–13.

Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET. Metabolic and body composition factors in subgroups of obesity: what do we know? Journal of Clinical Endocrinology and Metabolism. 2004;89(6):2569–75.

Vila M, Ru´ız O, Belmonte M. Changes in lipid profile and insulin resistance in obese patients after Scopinaro biliopancreatic diversion. Obesity Surgery. 2009;19(3):299–306.

Nguyen NT, Varela E, Sabio A, Tran CL, Stamos M, Wilson SE. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. Journal of the American College of Surgeons. 2006;vol. 203, no.1:24–9.

Fried M, Hainer V, Basdevant A. Interdisciplinary European guidelines on surgery of severe obesity. Obes Facts. 2008;1:52-9.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol. 2004;44:720-32.

Sjöstrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-93.

Sjöstrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273:219-34.

Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577-85.

DeAquino LA, Pereira SE, de Souza Silva J. Bariatric surgery: impact on body composition after Roux-en-Y gastric bypass. Obes Surg. 2012;22:195-200.

Patti ME, Houten SM, Bianco AC, Bernier R, Larsen PR. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring). 2009;17:1671-7.

Strain GW, Zhang F, Lei W. Changes in lipid profiles in morbidly obese patients after laparoscopic sleeve gastrectomy (LSG). Obes Surg. 2011;21:305-9.

Feng Z, Strain W, Lei W. Changes in lipid profiles in morbidly obese patients after laparoscopic sleeve gastrectomy. Obes Surg. 2011;21:305–9. doi: 10.1007/s11695-010-0285-x.

Dixon JB, O’Brien PE. Lipid profile in the severely obese: changes with weightloss afterlap-band surgery. Obes Res. 2002;10:903-10.

Wolf AM, Beisiegel U. The effect of loss of excess weight on the metabolic risk factor after bariatric surgery in morbidly and super-obese patients. Obes Surg. 2007;17:910-9.

Vidal J, Ibarzadal A, Romero F. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg. 2008;18:1077-82.

Hakeam HA, O'Regan PJ, Salem AM. Inhibition of C-reactive protein in morbidly obese patients after laparoscopic sleeve gastrectomy. Obes Surg. 2009;19:456-60.